Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Four-period amphetamine sensitization study with baseline dopamine PET in healthy men
NL-OMON38881Active, not recruiting
- Sponsor
- Centre for Human Drug Research
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of adenosine-5′-monophosphate, sponsored by Centre for Human Drug Research. Primary endpoints: Ventral striatum dopamine release, Saccadic eye movements and 13 more. Started May 2014; status: active, not recruiting.
02
Drugs
adenosine-5′-monophosphate
Beyond the preview
Go deeper on NL-OMON38881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38881.